Aspen closes R22bn credit line with international lenders
The credit will be used to refinance its syndicated loan facilities from 2018
08 November 2022 - 12:41
SA’s biggest pharmaceutical manufacturer, Aspen Pharmacare, has closed its multi-currency, syndicated term loan and revolving credit facilities agreement totalling €1.26bn (R22.4bn), to refinance its syndicated loan facilities from 2018.
“We are very pleased with the outcome of this syndication, particularly noting the current global risk-off sentiment. It is encouraging to see that all invited lenders have supported the transaction, which is testament to their confidence in the Aspen Group,” group CEO Stephen Saad said in a brief statement...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.